BLISS GVS PHARMA
Back to Balance Sheet
|
BLISS GVS PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,301 Cr | ₹1,212 Cr | ₹1,154 Cr | ₹1,109 Cr | ₹1,077 Cr |
What is the latest Total Liabilities ratio of BLISS GVS PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,301 Cr |
| Mar2024 | ₹1,212 Cr |
| Mar2023 | ₹1,154 Cr |
| Mar2022 | ₹1,109 Cr |
| Mar2021 | ₹1,077 Cr |
How is Total Liabilities of BLISS GVS PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,301 Cr | 7.37 | |
| Mar2024 | ₹1,212 Cr | 5.03 | |
| Mar2023 | ₹1,154 Cr | 4.04 | |
| Mar2022 | ₹1,109 Cr | 2.97 | |
| Mar2021 | ₹1,077 Cr | - | |
Compare Total Liabilities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹2,733.3 Cr | -0.1% | 27.1% | 122.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | -0.1% |
27.1% |
122.7% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses